People with glioblastoma are being deprived of the best chance of survival: easy access to clinical trials and off-label treatments, according to a survey of 162 patients and caregivers conducted by OurBrainBank.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe